Predicting morbidity of liver resection

Langenbecks Arch Surg. 2018 May;403(3):359-369. doi: 10.1007/s00423-018-1656-3. Epub 2018 Feb 7.

Abstract

Purpose: Multiple models have attempted to predict morbidity of liver resection (LR). This study aims to determine the efficacy of American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) surgical risk calculator and the Physiological and Operative Severity Score in the enUmeration of Mortality and Morbidity (POSSUM) in predicting post-operative morbidity in patients who underwent LR.

Methods: A retrospective analysis was conducted on patients who underwent elective LR. Morbidity risk was calculated with the ACS-NSQIP surgical risk calculator and POSSUM equation. Two models were then constructed for both ACS-NSQIP and POSSUM-(1) the original risk probabilities from each scoring system and (2) a model derived from logistic regression of variables. Discrimination, calibration, and overall performance for ACS-NSQIP and POSSUM were compared. Sub-group analysis was performed for both primary and secondary liver malignancies.

Results: Two hundred forty-five patients underwent LR. Two hundred twenty-three (91%) had malignant liver pathologies. The post-operative morbidity, 90-day mortality, and 30-day mortality rate were 38.3%, 3.7%, and 2.4% respectively. ACS-NSQIP showed superior discriminative ability, calibration, and performance to POSSUM (p = 0.03). Hosmer-Lemeshow plot demonstrated better fit of the ACS-NSQIP model than POSSUM in predicting morbidity.

Conclusion: In patients undergoing LR, the ACS-NSQIP surgical risk calculator was superior to POSSUM in predicting morbidity risk.

Keywords: ACS-NSQIP; Liver resection; Model; Morbidity; POSSUM.

MeSH terms

  • Aged
  • Cohort Studies
  • Disease-Free Survival
  • Elective Surgical Procedures / adverse effects*
  • Elective Surgical Procedures / methods
  • Elective Surgical Procedures / mortality
  • Female
  • Hepatectomy / adverse effects*
  • Hepatectomy / methods
  • Humans
  • Incidence
  • Liver Diseases / mortality*
  • Liver Diseases / pathology
  • Liver Diseases / surgery*
  • Liver Neoplasms / mortality
  • Liver Neoplasms / pathology
  • Liver Neoplasms / surgery
  • Logistic Models
  • Male
  • Middle Aged
  • Morbidity
  • Postoperative Complications / epidemiology
  • Postoperative Complications / physiopathology*
  • Predictive Value of Tests
  • Retrospective Studies
  • Risk Assessment
  • Survival Analysis
  • Treatment Outcome
  • United States